Skip to main content
. 2022 Mar 4;54(1):743–753. doi: 10.1080/07853890.2022.2045347

Table 5.

Effect of PM for Injection on median survival of subcutaneously transplanted mice with human Burkitt's lymphoma Raji cell line.

Group Control Vehicle PM 10mg/kg PM 20mg/kg HyperCVAD
Median survival (day) 14 14 30bei 30 bei 16

vs Control, ap < .05; bp < .01; c p < .001; vs Vehicle, dp < .05; ep < .01; fp < .001; vs Hyper-CVAD, gp < .05; hp < .01; ip < .001.